These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38041815)

  • 1. VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.
    Banerjee K; Kerzel T; Bekkhus T; de Souza Ferreira S; Wallmann T; Wallerius M; Landwehr LS; Agardy DA; Schauer N; Malmerfeldt A; Bergh J; Bartish M; Hartman J; Östman A; Squadrito ML; Rolny C
    Cell Rep; 2023 Dec; 42(12):113507. PubMed ID: 38041815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
    Ding M; Fu X; Tan H; Wang R; Chen Z; Ding S
    Mol Med Rep; 2012 Nov; 6(5):1023-9. PubMed ID: 22923155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival.
    Schoppmann SF; Fenzl A; Nagy K; Unger S; Bayer G; Geleff S; Gnant M; Horvat R; Jakesz R; Birner P
    Surgery; 2006 Jun; 139(6):839-46. PubMed ID: 16782443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
    Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
    Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Wang MH; Zha XM; Zhao Y; Wang S
    Med Oncol; 2012 Dec; 29(4):2594-600. PubMed ID: 22562155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
    Schoppmann SF; Birner P; Stöckl J; Kalt R; Ullrich R; Caucig C; Kriehuber E; Nagy K; Alitalo K; Kerjaschki D
    Am J Pathol; 2002 Sep; 161(3):947-56. PubMed ID: 12213723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.
    Tuomela J; Valta M; Seppänen J; Tarkkonen K; Väänänen HK; Härkönen P
    BMC Cancer; 2009 Oct; 9():362. PubMed ID: 19821979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.
    Wakisaka N; Hirota K; Kondo S; Sawada-Kitamura S; Endo K; Murono S; Yoshizaki T
    Oral Oncol; 2012 Aug; 48(8):703-8. PubMed ID: 22366442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
    J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.